These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11800349)

  • 1. Combination therapy in peripheral vascular disease: the rationale of using both thrombolytic and antiplatelet drugs.
    Shlansky-Goldberg R
    J Am Coll Surg; 2002 Jan; 194(1 Suppl):S103-13. PubMed ID: 11800349
    [No Abstract]   [Full Text] [Related]  

  • 2. GP IIb/IIIa blockade during peripheral artery interventions.
    Tepe G; Wiskirchen J; Pereira P; Claussen CD; Miller S; Duda SH
    Cardiovasc Intervent Radiol; 2008; 31(1):8-13. PubMed ID: 17479207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of concomitant glycoprotein IIb/IIIa inhibitors with catheter-directed peripheral arterial thrombolysis.
    Ouriel K
    J Vasc Interv Radiol; 2004 Jun; 15(6):543-6. PubMed ID: 15178713
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombolytic therapy: new dimensions 2009.
    Guha S; Mukherjee S; Hema MB
    Indian Heart J; 2009; 61(5):415-21. PubMed ID: 20635755
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombocyte IIb/IIIa receptor inhibitors--a new direction in antithrombotic therapy].
    Panchenko EP
    Ter Arkh; 1997; 69(9):66-71. PubMed ID: 9411833
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist.
    Mousa SA; DeGrado WF; Mu DX; Kapil RP; Lucchesi BR; Reilly TM
    Circulation; 1996 Feb; 93(3):537-43. PubMed ID: 8565173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis and therapy of the acute coronary syndrome: differentiated advantage of glycoprotein IIb/IIIa receptor antagonists for high-risk patients].
    Münzel TF; Post F
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S215-8. PubMed ID: 17109252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: the 'OPTIMIZE-IT' pilot randomized study.
    Talarico GP; Brancati M; Burzotta F; Porto I; Trani C; De Vita M; Todaro D; Giammarinaro M; Leone AM; Niccoli G; Andreotti F; Mazzari MA; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):245-51. PubMed ID: 19262211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoprotein IIb/IIIa antagonist and fibrinolytic agents: new therapeutic regimen for acute myocardial infarction.
    Patel VB; Moliterno DJ
    J Invasive Cardiol; 2000 Mar; 12 Suppl B():8B-15B. PubMed ID: 10731294
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycoprotein IIb/IIIa inhibitors: therapeutic applications in acute ST-segment elevation myocardial infarction.
    Campbell KR; Cantor W; Sketch M; Ohman EM
    Am Heart J; 2000 Dec; 140(6 Suppl):S115-24. PubMed ID: 11100005
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia.
    Peter K; Straub A; Kohler B; Volkmann M; Schwarz M; Kübler W; Bode C
    Am J Cardiol; 1999 Sep; 84(5):519-24. PubMed ID: 10482148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy for acute myocardial infarction: glycoprotein IIb/IIIa inhibitors plus thrombolysis.
    Cannon CP
    Clin Cardiol; 1999 Aug; 22(8 Suppl):IV37-43. PubMed ID: 10492852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitation of thrombolysis in acute myocardial infarction.
    Gambhir DS
    Indian Heart J; 1999; 51(5):486-8. PubMed ID: 10721636
    [No Abstract]   [Full Text] [Related]  

  • 14. The glycoprotein IIb/IIIa platelet receptor blocker tirofiban, but not heparin, counteracts platelet aggregation in unstable angina pectoris.
    Mattsson E; Martinsson A; Nyqvist O; Rasmanis G; Sylvén C; Karlberg KE
    Am J Cardiol; 1997 Oct; 80(7):938-40. PubMed ID: 9382012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Roe MT; Sapp SK; Lincoff AM
    Cleve Clin J Med; 2000 Feb; 67(2):131-40. PubMed ID: 10680279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet glycoprotein IIb/IIIa receptor blockade in unstable coronary disease.
    Chesebro JH; Badimon JJ
    N Engl J Med; 1998 May; 338(21):1539-41. PubMed ID: 9593795
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of glycoprotein IIb/IIIa antagonists in peripheral arterial occlusion.
    Ouriel K
    Tech Vasc Interv Radiol; 2001 Jun; 4(2):107-10. PubMed ID: 11981796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
    Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
    J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming thrombolytic resistance: rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarction.
    Cannon CP
    J Am Coll Cardiol; 1999 Nov; 34(5):1395-402. PubMed ID: 10551684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Fernandez JS; Sadaniantz A
    Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.